BARCLAYS PLC's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters.
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Interest and similar income | $36.2B | $38.3B | $35.1B | $19.1B |
| Interest and similar expense | ($21.7B) | ($25.4B) | ($22.4B) | ($8.5B) |
| Net interest income | $14.5B | $12.9B | $12.7B | $10.6B |
| Fee and commission income | $11.3B | $10.8B | $10.1B | $9.6B |
| Fee and commission expense | ($3.8B) | ($3.6B) | ($3.6B) | ($3.0B) |
| Net fee and commission income | $7.5B | $7.2B | $6.5B | $6.6B |
| Net trading income | $7.0B | $5.8B | $5.9B | $8.0B |
| Net investment income | $10.0M | $216.0M | — | ($434.0M) |
| Gain on acquisition | $0 | $556.0M | — | — |
| Other income | $89.0M | $65.0M | $134.0M | $170.0M |
| Total income | $29.1B | $26.8B | $25.4B | $25.0B |
| Staff costs | ($10.6B) | ($9.9B) | ($10.0B) | ($9.3B) |
| Infrastructure costs | ($3.7B) | ($3.5B) | ($4.1B) | ($3.4B) |
| Administration and general expenses | ($2.7B) | ($2.8B) | ($2.8B) | ($2.4B) |
| UK regulatory levies | ($313.0M) | ($320.0M) | — | — |
| Litigation and conduct | ($392.0M) | ($220.0M) | ($37.0M) | ($1.6B) |
| Operating expenses | ($17.7B) | ($16.7B) | ($16.9B) | ($16.7B) |
| Share of post-tax results of associates and joint ventures | $66.0M | $37.0M | ($9.0M) | $6.0M |
| Loss on disposal of subsidiaries, associates and joint ventures | ($43.0M) | — | — | $0 |
| Profit before impairment | $11.4B | $10.1B | $8.4B | $8.2B |
| Credit impairment charges | ($2.3B) | ($2.0B) | ($1.9B) | ($1.2B) |
| Profit before tax | $9.1B | $8.1B | $6.6B | $7.0B |
| Taxation | ($1.9B) | ($1.8B) | ($1.2B) | ($1.0B) |
| Ordinary equity holders | $6.2B | $5.3B | $4.3B | $5.0B |
| Other equity instrument holders | $997000000.00 | $991000000.00 | $985000000.00 | $905000000.00 |
| Total equity holders of the parent | $7.2B | $6.3B | $5.3B | $5.9B |
| Non-controlling interests | $41.0M | $49.0M | $64.0M | $45.0M |
| Profit after tax | $7.2B | $6.4B | $5.3B | $6.0B |
| Basic earnings per ordinary share (in GBP per share) | $0.44 | $0.36 | $0.28 | $0.31 |
| Diluted earnings per ordinary share (in GBP per share) | $0.42 | $0.35 | $0.27 | $0.30 |
| Line item | Jun 30, 2026 · YTD | Jun 30, 2025 · YTD | Jun 30, 2024 · YTD | Jun 30, 2023 · YTD |
|---|---|---|---|---|
| Interest and similar income | $17.4B | $18.3B | $18.6B | $15.6B |
| Interest and similar expense | ($9.8B) | ($11.2B) | ($12.5B) | ($9.3B) |
| Net interest income | $7.7B | $7.0B | $6.1B | $6.3B |
| Fee and commission income | $5.9B | $5.7B | $5.4B | $5.3B |
| Fee and commission expense | ($2.0B) | ($2.0B) | ($1.7B) | ($1.9B) |
| Net fee and commission income | $4.0B | $3.7B | $3.7B | $3.4B |
| Net trading income | $4.6B | $4.2B | $3.2B | $3.8B |
| Net investment income/(expense) | $4.0M | ($18.0M) | — | — |
| Other income | $257.0M | $37.0M | $23.0M | $44.0M |
| Total income | $16.5B | $14.9B | $13.3B | $13.5B |
| Staff costs | ($5.7B) | ($5.3B) | ($5.0B) | ($5.0B) |
| Infrastructure, administration and general expenses | ($3.2B) | ($3.2B) | ($3.0B) | ($3.0B) |
| UK regulatory levies | ($84.0M) | ($96.0M) | ($120.0M) | — |
| Litigation and conduct | ($108.0M) | ($87.0M) | ($64.0M) | ($32.0M) |
| Operating expenses | ($9.1B) | ($8.6B) | ($8.2B) | ($8.1B) |
| Share of post-tax results of associates and joint ventures | $24.0M | $9.0M | $16.0M | ($2.0M) |
| Profit before impairment | $7.5B | $6.3B | $5.1B | $5.5B |
| Credit impairment charges | ($1.4B) | ($1.1B) | ($897.0M) | ($896.0M) |
| Profit before tax | $6.1B | $5.2B | $4.2B | $4.6B |
| Tax charge | ($1.4B) | ($1.2B) | ($892.0M) | ($914.0M) |
| Shareholders of the parent | $4.2B | $3.5B | $2.8B | $3.1B |
| Other equity holders | $487000000.00 | $484000000.00 | $510000000.00 | $507000000.00 |
| Equity holders of the parent | $4.7B | $4.0B | $3.3B | $3.6B |
| Non-controlling interests | $19.0M | $23.0M | $26.0M | $30.0M |
| Profit after tax | $4.7B | $4.0B | $3.3B | $3.6B |
| Basic earnings per ordinary share (in GBP per share) | $0.31 | $0.25 | $0.19 | $0.20 |
| Diluted earnings per ordinary share (in GBP per share) | $0.30 | $0.24 | $0.18 | $0.19 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and balances at central banks | $229.8B | $210.2B | $224.6B | $256.4B |
| Cash collateral and settlement balances | $130.5B | $119.8B | $108.9B | $112.6B |
| Debt securities at amortised cost | $68.5B | $68.2B | $56.7B | — |
| Loans and advances at amortised cost to banks | $8.6B | $8.3B | $9.5B | — |
| Loans and advances at amortised cost to customers | $352.9B | $337.9B | $333.3B | — |
| Reverse repurchase agreements and other similar secured lending at amortised cost | $17.6B | $4.7B | $2.6B | $776.0M |
| Trading portfolio assets | $190.1B | $166.5B | $174.6B | $133.8B |
| Financial assets at fair value through the income statement | $186.9B | $193.7B | $206.7B | $213.6B |
| Derivative financial instruments | $252.5B | $293.5B | $256.8B | $302.4B |
| Financial assets at fair value through other comprehensive income | $74.4B | $78.1B | $71.8B | $65.1B |
| Investments in associates and joint ventures | $739.0M | $891.0M | $879.0M | $922.0M |
| Goodwill and intangible assets | $8.3B | $8.3B | $7.8B | $8.2B |
| Property, plant and equipment | $3.7B | $3.6B | $3.4B | $3.6B |
| Current tax assets | $276.0M | $155.0M | $121.0M | $385.0M |
| Deferred tax assets | $5.0B | $6.3B | $6.0B | $7.0B |
| Retirement benefit assets | $3.3B | $3.3B | $3.7B | $4.7B |
| Assets included in disposal group classified as held for sale | $5.9B | $9.9B | $3.9B | — |
| Other assets | $5.2B | $4.8B | $6.2B | $5.5B |
| Total assets | $1.5T | $1.5T | $1.5T | $1.5T |
| Deposits at amortised cost from banks | $20.4B | $13.2B | $14.5B | — |
| Deposits at amortised cost from customers | $565.2B | $547.5B | $524.3B | — |
| Cash collateral and settlement balances | $117.6B | $106.2B | $94.1B | $96.9B |
| Repurchase agreements and other similar secured borrowing at amortised cost | $25.2B | $39.4B | $41.6B | $27.1B |
| Debt securities in issue | $119.0B | $92.4B | $96.8B | $112.9B |
| Subordinated liabilities | $13.0B | $11.9B | $10.5B | $11.4B |
| Trading portfolio liabilities | $57.7B | $56.9B | $58.7B | $72.9B |
| Financial liabilities designated at fair value | $294.1B | $282.2B | $297.5B | $271.6B |
| Derivative financial instruments | $240.8B | $279.4B | $250.0B | $289.6B |
| Current tax liabilities | $868.0M | $566.0M | $529.0M | $580.0M |
| Deferred tax liabilities | $13.0M | $18.0M | $22.0M | $16.0M |
| Retirement benefit liabilities | $265.0M | $240.0M | $266.0M | $264.0M |
| Provisions | $1.7B | $1.4B | $1.6B | $1.5B |
| Liabilities included in disposal group classified as held for sale | $0 | $3.7B | $3.2B | — |
| Other liabilities | $10.1B | $10.6B | $12.0B | $13.8B |
| Total liabilities | $1.5T | $1.4T | $1.4T | $1.4T |
| Called up share capital and share premium | $4.2B | $4.2B | $4.3B | $4.4B |
| Other equity instruments | $12.7B | $12.1B | $13.3B | $13.3B |
| Other reserves | $1.6B | ($468.0M) | ($77.0M) | ($2.2B) |
| Retained earnings | $59.3B | $56.0B | $53.7B | $52.8B |
| Total equity excluding non-controlling interests | $77.8B | $71.8B | $71.2B | $68.3B |
| Non-controlling interests | $452.0M | $660.0M | $660.0M | $968.0M |
| Total equity | $78.2B | $72.5B | $71.9B | $69.3B |
| Total liabilities and equity | $1.5T | $1.5T | $1.5T | $1.5T |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 |
|---|---|---|---|---|
| Cash and balances at central banks | $245.9B | $225.7B | $243.5B | $252.8B |
| Cash collateral and settlement balances | $189.5B | $152.3B | $146.8B | $130.5B |
| Debt securities at amortised cost | $73.5B | $69.9B | $61.7B | $53.1B |
| Loans and advances at amortised cost to banks | $12.0B | $8.7B | $8.0B | $10.9B |
| Loans and advances at amortised cost to customers | $359.3B | $339.1B | $329.8B | $337.4B |
| Reverse repurchase agreements and other similar secured lending at amortised cost | $12.1B | $7.9B | $4.7B | $2.6B |
| Trading portfolio assets | $210.1B | $187.2B | $197.3B | $165.8B |
| Financial assets at fair value through the income statement | $213.1B | $218.6B | $215.2B | $235.1B |
| Derivative financial instruments | $303.6B | $280.2B | $253.6B | $266.3B |
| Financial assets at fair value through other comprehensive income | $83.0B | $77.3B | $82.7B | $66.1B |
| Investments in associates and joint ventures | $732.0M | $913.0M | $876.0M | $900.0M |
| Goodwill and intangible assets | $8.9B | $8.2B | $7.8B | $8.6B |
| Property, plant and equipment | $4.2B | $3.5B | $3.6B | $3.5B |
| Current tax assets | $222.0M | $174.0M | $176.0M | $100.0M |
| Deferred tax assets | $5.0B | $5.2B | $6.3B | $7.4B |
| Retirement benefit assets | $3.3B | $3.0B | $3.5B | $4.1B |
| Assets included in a disposal group classified as held for sale | $0 | $5.6B | $3.7B | — |
| Other assets | $5.9B | $5.1B | $7.2B | $4.5B |
| Total assets | $1.7T | $1.6T | $1.6T | $1.5T |
| Deposits at amortised cost from banks | $19.9B | $19.3B | $19.4B | $26.8B |
| Deposits at amortised cost from customers | $574.4B | $545.2B | $538.1B | $527.8B |
| Cash collateral and settlement balances | $182.1B | $140.0B | $144.6B | $115.2B |
| Repurchase agreements and other similar secured borrowings at amortised cost | $30.7B | $35.5B | $52.4B | $41.2B |
| Debt securities in issue | $126.8B | $104.9B | $96.8B | $105.0B |
| Subordinated liabilities | $11.1B | $12.5B | $11.8B | $11.0B |
| Trading portfolio liabilities | $78.4B | $69.3B | $59.3B | $71.0B |
| Financial liabilities designated at fair value | $321.9B | $317.5B | $321.0B | $314.7B |
| Derivative financial instruments | $291.8B | $265.4B | $242.1B | $254.8B |
| Current tax liabilities | $1.0B | $905.0M | $686.0M | $675.0M |
| Deferred tax liabilities | $13.0M | $18.0M | $22.0M | $16.0M |
| Retirement benefit liabilities | $266.0M | $244.0M | $277.0M | $261.0M |
| Provisions | $1.7B | $1.4B | $1.3B | $1.4B |
| Other liabilities | $10.3B | $10.2B | $13.2B | $11.2B |
| Total liabilities | $1.7T | $1.5T | $1.5T | $1.5T |
| Called up share capital and share premium | $4.2B | $4.2B | $4.3B | $4.3B |
| Other equity instruments | $13.3B | $13.3B | $13.0B | $13.8B |
| Other reserves | $1.5B | $693.0M | ($882.0M) | ($4.5B) |
| Retained earnings | $60.4B | $57.7B | $54.8B | $54.0B |
| Total equity excluding non-controlling interests | $79.4B | $75.9B | $71.2B | $67.7B |
| Non-controlling interests | $453.0M | $449.0M | $660.0M | $876.0M |
| Total equity | $79.8B | $76.4B | $71.8B | $68.5B |
| Total liabilities and equity | $1.7T | $1.6T | $1.6T | — |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Profit before tax | $9.1B | $8.1B | $6.6B | $7.0B |
| Credit impairment charges | $2.3B | $2.0B | — | — |
| Depreciation, amortisation and impairment of property, plant, equipment and intangibles | $1.8B | $1.7B | $2.1B | $1.8B |
| Other provisions, including pensions | $760.0M | $500.0M | $482.0M | $1.7B |
| Net loss on disposal of investments and property, plant and equipment | $52.0M | $20.0M | $11.0M | $54.0M |
| Other non-cash movements, including exchange rate movements | $6.2B | $2.4B | $10.7B | ($13.3B) |
| Net decrease in cash collateral and settlement balances | $1.4B | $2.4B | $1.2B | ($881.0M) |
| Net (increase)/decrease in loans and advances at amortised cost | ($17.4B) | $284.0M | — | — |
| Net increase in reverse repurchase agreements and other similar secured lending | ($12.9B) | ($2.1B) | ($1.8B) | $2.5B |
| Net increase/(decrease) in deposits at amortised cost | $24.9B | $15.0B | — | — |
| Net increase/(decrease) in debt securities in issue | $20.9B | ($10.0B) | — | $9.2B |
| Net (decrease)/increase in repurchase agreements and other similar secured borrowing | ($14.2B) | ($2.2B) | $14.5B | ($1.3B) |
| Net decrease/(increase) in derivative financial instruments | $2.5B | ($7.3B) | $6.0B | ($7.1B) |
| Net (increase)/decrease in trading portfolio assets | ($23.6B) | $8.2B | ($40.8B) | $13.2B |
| Net increase/(decrease) in trading portfolio liabilities | $829.0M | ($1.8B) | ($14.3B) | $18.8B |
| Net increase/(decrease) in financial assets and liabilities at fair value through the income statement | $18.8B | — | $32.8B | ($919.0M) |
| Net increase in other assets | ($158.0M) | ($4.0B) | ($1.5B) | ($3.5B) |
| Net increase/(decrease) in other liabilities | ($1.1B) | ($2.3B) | ($2.4B) | $1.1B |
| Corporate income tax paid | ($1.4B) | ($1.3B) | ($836.0M) | ($688.0M) |
| Net cash from operating activities | $18.7B | $7.1B | ($927.0M) | $30.2B |
| Purchase of debt securities at amortised cost | ($19.2B) | ($28.9B) | ($20.0B) | ($27.7B) |
| Proceeds from redemption or sale of debt securities at amortised cost | $17.9B | $17.5B | $7.3B | $14.3B |
| Purchase of financial assets at fair value through other comprehensive income | ($50.5B) | ($81.0B) | ($66.4B) | ($69.4B) |
| Proceeds from sale or redemption of financial assets at fair value through other comprehensive income | $55.1B | $73.8B | $59.8B | $62.8B |
| Purchase of property, plant and equipment and investment in intangibles | ($1.9B) | ($1.6B) | ($1.7B) | ($1.7B) |
| Disposal/(Acquisition) of business | $0 | — | — | — |
| Other cash flows associated with investing activities | $234.0M | $2.7B | $23.0M | $86.0M |
| Net cash from investing activities | $1.6B | ($17.9B) | ($23.4B) | ($21.7B) |
| Dividends paid and other coupon payments on equity instruments | ($2.3B) | ($2.3B) | ($2.3B) | ($2.0B) |
| Issuance of subordinated liabilities | $1.8B | $1.9B | $1.5B | $1.5B |
| Redemption of subordinated liabilities | ($727.0M) | ($476.0M) | ($2.2B) | ($2.7B) |
| Issue of shares and other equity instruments | 3.9B | 1.7B | 3.3B | 3.2B |
| Repurchase of shares and other equity instruments | -5.6B | -4.5B | -4.8B | -3.7B |
| Issuance of debt securities | $11.3B | $12.1B | $9.8B | $11.1B |
| Redemption of debt securities | ($5.5B) | ($7.1B) | ($6.3B) | ($6.3B) |
| Capital contribution | ($40.0M) | — | — | — |
| Net purchase of treasury shares | -590.0M | -509.0M | -499.0M | -478.0M |
| Net cash from financing activities | $2.3B | $784.0M | ($1.4B) | $696.0M |
| Effect of exchange rates on cash and cash equivalents | ($1.7B) | ($2.4B) | ($5.1B) | $10.3B |
| Net increase/(decrease) in cash and cash equivalents | $20.9B | ($12.4B) | ($30.8B) | $19.6B |
| Cash and cash equivalents at beginning of year | $235.6B | $248.0B | $278.8B | $259.2B |
| Cash and balances at central banks | $229.8B | $210.2B | $224.6B | $256.4B |
| Loans and advances to banks with original maturity of three months or less | $7.4B | $7.2B | $6.6B | $6.4B |
| Cash collateral balances with central banks with original maturity of three months or less | $17.4B | $16.6B | $15.4B | $15.2B |
| Treasury and other eligible bills with original maturity of three months or less | $2.0B | $1.5B | $1.3B | $858.0M |
| Line item | Jun 30, 2026 · YTD | Jun 30, 2025 · YTD | Jun 30, 2024 · YTD | Jun 30, 2023 · YTD |
|---|---|---|---|---|
| Profit before tax | $6.1B | $5.2B | $4.2B | $4.6B |
| Adjustment for non-cash and other items | $3.1B | $9.5B | $5.0B | $10.1B |
| Net increase in loans and advances at amortised cost | ($7.6B) | ($1.9B) | — | — |
| Net increase in deposits at amortised cost | $8.7B | $3.9B | $18.7B | $8.9B |
| Net increase in debt securities in issue | $3.7B | $8.2B | — | — |
| Changes in other operating assets and liabilities | $17.2B | ($3.8B) | $10.1B | $2.6B |
| Corporate income tax paid | ($793.0M) | ($712.0M) | ($540.0M) | ($346.0M) |
| Net cash from operating activities | $30.4B | $20.3B | $37.6B | $23.9B |
| Net cash from investing activities | ($11.0B) | ($4.2B) | ($16.3B) | ($14.8B) |
| Net cash from financing activities | ($1.1B) | $3.7B | $166.0M | ($191.0M) |
| Effect of exchange rates on cash and cash equivalents | $334.0M | ($2.6B) | ($1.6B) | ($6.1B) |
| Net increase in cash and cash equivalents | $18.7B | $17.2B | $19.8B | $2.9B |
| Cash and cash equivalents at beginning of the period | $256.5B | $235.6B | $248.0B | $278.8B |
| Cash and cash equivalents at end of the period | $275.1B | $252.8B | $267.8B | $281.7B |
BARCLAYS PLC score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.